Avid Bioservices (NASDAQ:CDMO – Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01, MarketWatch Earnings reports. Avid Bioservices had a negative net margin of 2.06% and a negative return on equity of 1.55%. The company had revenue of […]